Terms: = Lung cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Clinical Outcome
3 results:
1. Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition.
Chang H; Liu Y; Xue M; Liu H; Du S; Zhang L; Wang P
Nucleic Acids Res; 2016 Apr; 44(6):2514-27. PubMed ID: 26926107
[TBL] [Abstract] [Full Text] [Related]
2. EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.
Li S; Ma Y; Xie C; Wu Z; Kang Z; Fang Z; Su B; Guan M
Oncotarget; 2015 Sep; 6(26):22587-97. PubMed ID: 26041887
[TBL] [Abstract] [Full Text] [Related]
3. Transformation resistance in a premature aging disorder identifies a tumor-protective function of brd4.
Fernandez P; Scaffidi P; Markert E; Lee JH; Rane S; Misteli T
Cell Rep; 2014 Oct; 9(1):248-260. PubMed ID: 25284786
[TBL] [Abstract] [Full Text] [Related]
